Because ATGL is reduced or lost in human malignant epithelial and mesenchymal tumors and ATGL deficiency induces pulmonary neoplasia in an animal model, we propose that ATGL qualifies as a tumor suppressor. This evidence concerns the gene PNPLA2 and neoplasm.